a. Triple Receptor Mechanism
Retatrutide uniquely activates three different receptor systems:
● GLP-1 receptor: Enhances satiety, reduces appetite, and slows gastric emptying.
● GIP receptor: Promotes insulin secretion and supports anabolistic pathways.
● Glucagon receptor: Promotes lipid oxidation and increases energy expenditure.
This synergistic effect makes retatrutide a comprehensive metabolic regulator.
b. Metabolic Adaptability
It adjusts its action according to the user's metabolic needs, such as increasing lipid oxidation during calorie deficiency or reducing fat storage during calorie surplus.
c. Non-Stimulating
Unlike stimulants, retatrutide does not rely on central nervous system activation, making it safer for long-term use and preventing stress or insomnia.
d. Injectable Dosage Form
Retatrutide is typically administered via subcutaneous injection once weekly. Its long half-life ensures sustained action.
e. Biochemical stability
Its engineered structure resists enzyme degradation, prolongs its activity, and enhances its efficacy.
Whatsapp: ＋85246360786
sararaws128@gmail.com